Foresite Capital Management III as of June 30, 2016
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 18 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alder Biopharmaceuticals | 27.4 | $40M | 1.6M | 24.97 | |
| Aerie Pharmaceuticals | 16.2 | $24M | 1.3M | 17.60 | |
| Wave Life Sciences (WVE) | 13.8 | $20M | 970k | 20.69 | |
| Intellia Therapeutics (NTLA) | 11.2 | $16M | 764k | 21.35 | |
| Global Blood Therapeutics In | 7.9 | $12M | 690k | 16.59 | |
| Epizyme | 3.6 | $5.2M | 512k | 10.24 | |
| Ardelyx (ARDX) | 3.6 | $5.3M | 602k | 8.73 | |
| Avexis | 2.5 | $3.6M | 95k | 38.01 | |
| Neuroderm Ltd F | 2.2 | $3.3M | 202k | 16.25 | |
| Zafgen | 2.2 | $3.2M | 538k | 5.99 | |
| Syros Pharmaceuticals | 1.9 | $2.7M | 150k | 18.15 | |
| Bellicum Pharma | 1.8 | $2.7M | 206k | 12.96 | |
| Akari Therapeutics | 1.8 | $2.7M | 197k | 13.49 | |
| Aimmune Therapeutics | 1.7 | $2.5M | 235k | 10.82 | |
| Orexigen Therapeutics | 0.8 | $1.1M | 2.5M | 0.43 | |
| Lipocine | 0.6 | $920k | 303k | 3.04 | |
| Nanostring Technologies (NSTGQ) | 0.6 | $895k | 71k | 12.61 | |
| BioDelivery Sciences International | 0.1 | $166k | 70k | 2.37 |
